These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6812961)

  • 1. Low biological availability of ergotamine tartrate after oral dosing in cluster headache.
    Ekbom K; Paalzow L; Waldenlind E
    Cephalalgia; 1981 Dec; 1(4):203-7. PubMed ID: 6812961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal routes of administration of ergotamine tartrate in cluster headache patients. A pharmacokinetic study.
    Ekbom K; Krabbe AE; Paalzow G; Paalzow L; Tfelt-Hansen P; Waldenlind E
    Cephalalgia; 1983 Mar; 3(1):15-20. PubMed ID: 6406071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of ergotamine in migraine and cluster headache.
    Perrin VL
    Clin Pharmacokinet; 1985; 10(4):334-52. PubMed ID: 3899452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Br J Clin Pharmacol; 1983 Dec; 16(6):695-9. PubMed ID: 6419759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.
    Ala-Hurula V; Myllylä VV; Arvela P; Heikkilä J; Kärki N; Hokkanen E
    Eur J Clin Pharmacol; 1979 Feb; 15(1):51-5. PubMed ID: 421728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain relief by somatostatin in attacks of cluster headache.
    Sicuteri F; Geppetti P; Marabini S; Lembeck F
    Pain; 1984 Apr; 18(4):359-365. PubMed ID: 6145138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotaminism after a single dose of ergotamine tartrate.
    Harrison TE
    J Emerg Med; 1984; 2(1):23-5. PubMed ID: 6440914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic availability of ergotamine tartrate in healthy subjects after single and repeated oral doses.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():7-9. PubMed ID: 6935862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and therapeutic aspects of chronic cluster headache].
    Manzoni GC; Terzano MG; Lechi A
    Acta Biomed Ateneo Parmense; 1981; 52(1):11-9. PubMed ID: 6455027
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramuscular ergotamine: plasma levels and dynamic activity.
    Tfelt-Hansen P; Paalzow L
    Clin Pharmacol Ther; 1985 Jan; 37(1):29-35. PubMed ID: 3917386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical conferences at the Johns Hopkins Hospital: cluster headache.
    Sholar PW; Frank DH
    Johns Hopkins Med J; 1982 Jun; 150(6):246-50. PubMed ID: 6806518
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of pharmacodynamic effects and plasma levels of oral and rectal ergotamine.
    Bülow PM; Ibraheem JJ; Paalzow G; Tfelt-Hansen P
    Cephalalgia; 1986 Jun; 6(2):107-11. PubMed ID: 3091257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.
    Ala-Hurula V; Myllylä V; Hokkanen E
    Cephalalgia; 1982 Dec; 2(4):189-95. PubMed ID: 7159921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergotamine toxicity and serum concentrations of ergotamine in migraine patients.
    Graham AN; Johnson ES; Persaud NP; Turner P; Wilkinson M
    Hum Toxicol; 1984 Jun; 3(3):193-9. PubMed ID: 6430784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Eur J Clin Pharmacol; 1982; 23(3):235-40. PubMed ID: 7173294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.
    Ala-Hurula V; Myllylä VV; Arvela P; Kärki NT; Hokkanen E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):355-60. PubMed ID: 520404
    [No Abstract]   [Full Text] [Related]  

  • 17. [Doppler ultrasound studies of the extracranial cerebral vessels in migraine patients after ergotamine tartrate administration].
    Puzich R; Girke W; Heidrich H; Rischke M
    Dtsch Med Wochenschr; 1983 Mar; 108(12):457-61. PubMed ID: 6403323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Mathew NT
    Headache; 1997; 37 Suppl 1():S26-32. PubMed ID: 9009471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug management of adult vascular headaches (migraine and cluster headache): Part II--Prevention and attacks.
    Damasio H
    Iowa Med; 1984 Dec; 74(12):536, 538-9. PubMed ID: 6440873
    [No Abstract]   [Full Text] [Related]  

  • 20. Linear pharmacokinetics of intravenous ergotamine tartrate.
    Ibraheem JJ; Paalzow L; Tfelt-Hansen P
    Eur J Clin Pharmacol; 1985; 29(1):61-6. PubMed ID: 3932078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.